![PWS Research Symposium Highlights [2018 Conference Video]](https://www.fpwr.org/hubfs/Blog_Images/pws-research-symposium-highlights-2018-conference-video.jpg)
This blog is based on a presentation at the FPWR 2018 conference. You can watch the complete presentation by clicking on the embedded video. If you don't have time to watch the full video, we've included a full transcript of the presentation below. You can also watch the full set of conference...
Source: FPWR Blog
|
Published: March 3 2019 - 09:00 AM
We’re looking forward to this year’s FPWR Family Conference, and I hope you will join me at two informative sessions with Ashley Waguespack and Jessica Boudreaux, of Sensory Solutions. Ashley and Jessica have more than 20 years combined experience to the field of pediatric occupational therapy....
Source: FPWR Blog
|
Published: March 3 2019 - 08:00 AM
Millendo Therapeutics recently announced the initiation of their Pivotal Phase 2b/3 clinical study of Livoletide for the treatment of Prader-Willi syndrome. This study which is investigating the efficacy of livoletide on food-related behaviors in PWS, will be enrolling approximately 150 patients...
Source: FPWR Blog
|
Published: March 3 2019 - 11:49 AM
Source: FPWR Blog
|
Published: March 3 2019 - 10:10 AM
Several NEW PWS trial opportunities are now available. FPWR maintains the latest clinical trial information so that you can stay abreast of trial opportunities. Some trials require in-person visits while others can be completed remotely. Some trials are testing new drugs while others are...
Source: FPWR Blog
|
Published: March 3 2019 - 09:00 AM